Home>Topics>>Amgen: Equity Report And Stock Valuation
Amgen: Equity Report And Stock Valuation
Long Investing Ideas from Seeking Alpha
Mon, 3 Dec 2012
By Bio Vantage : Executive Summary Amgen ( AMGN ) is among the largest global biotechnology companies, with a $68B market cap and over $15.5B in combined sales in 2011. Our research shows that Amgen will have significant revenue growth from several key drugs that have been approved since 2006. As ...
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.